Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
[18F]FTC-146 PET/MRI in Pediatric Chronic Pain
NCT04435821Phase 1Completed
- Sponsor
- Stanford University
- Start
- Nov 2020
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of [18F]-FTC-146 in chronic pain, sponsored by Stanford University. Primary endpoint: [18F]FTC-146 Biodistribution in Pain Patients at 3 hours. Started Nov 2020; status: completed.
02
Drugs
[18F]-FTC-146
03
Conditions
chronic pain
Beyond the preview
Go deeper on NCT04435821.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04435821.